AzTrials
AzTrials

MicrogravityNCT06350422

Neuroimage Genome Study of Neuroplasticity Associated With Microgravity

An observational study of Microgravity and Neuroplasticity, run by Chinese PLA General Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This clinical trial investigates the neuroplasticity and cognitive status changes of the human brain in microgravity. To explore the relationship between cognitive status changes and brain functional activities, gray matter and white matter changes under microgravity exposure, screen and identify representative image… Read more about this study

Who is it for?
Ages 18 to 60 years, men onlyHealthy volunteers can take part
Conditions the study is for
Microgravity, Neuroplasticity, MRI
What is being tested?
Head-Down tilt Bed Rest test
How many people
26 participants
Where
1 siteChina
Study dates
1 Jan 2022to 31 Dec 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Study population: Volunteers who underwent 60 days of the Head-Down tilt Bed Rest test.

Who may be able to join

  • Male aged 18-60 years
  • No mental or other neurological disorders, no history of drug or alcohol abuse
  • Generally in good condition, no clear major physical diseases, no hearing disorders
  • No metal foreign bodies in the body, no contraindications to MRI scanning
  • No claustrophobia
  • Agree to participate in the clinical study and sign the informed consent

Who cannot join

  • There are electronic implants or metal foreign bodies, such as cardiac pacemakers
  • People with aneurysm surgery and intracranial aneurysm clip
  • People who have had heart surgery and used artificial heart valves
  • Having family planning
  • Uncontrolled epilepsy or mental illness, can't cooperate with MRI examination
  • Severe claustrophobia, can't cooperate with magnetic resonance examination
  • Other circumstances that the clinical trial personnel consider inappropriate to participate in the study

Trial locations and contacts

1 site in 1 country.

China1 site
  • Chinese PLA General Hospital

    Beijing

Other trials in China

About this study

This clinical trial investigates the neuroplasticity and cognitive status changes of the human brain in microgravity. To explore the relationship between cognitive status changes and brain functional activities, gray matter and white matter changes under microgravity exposure, screen and identify representative image markers, so as to provide decision-making information for the cognitive status changes of relevant personnel under microgravity environment.

Read the detailed description

MRI has the advantage of non-invasive and non-radiation, and imaging the human brain after exposure to microgravity can reveal the neuroplastic changes in the astronaut's brain and discover the characteristics of functional activities behind it. The purpose of this study is to explore the image features and cognitive state related information related to the changes of human brain neuroplasticity under microgravity environment, and to identify the related image markers. At the same time, the pathophysiological mechanism is preliminarily discussed in this study. This study is helpful for us to explore the sensitivity of different brain structures and brain functions to space microgravity environment, so as to further understand the role and influence of space missions on brain health.

Being tested
Head-Down tilt Bed Rest test
Keywords
Microgravity, Neuroplasticity, MRI, Repeatable Battery for the Assessment of Neuropsychological Status

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Head-Down tilt Bed Rest testOther

    All of the volunteers underwent 60 days of the Head-Down tilt Bed Rest test.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Local brain functional activity

    Based on resting-state functional MRI images, the changes of local brain functional activity before and after the Head-Down tilt Bed Rest test were compared.

    Measured: 60 days after the Head-Down tilt Bed Rest test

  2. Brain functional connectivity

    Based on resting-state functional MRI images, the changes of brain functional connectivity before and after the Head-Down tilt Bed Rest test were compared.

    Measured: 60 days after the Head-Down tilt Bed Rest test

  3. Brain structure - Morphology

    Based on 3D-T1WI, the changes of brain structure before and after the Head-Down tilt Bed Rest test were compared.

    Measured: 60 days after the Head-Down tilt Bed Rest test

  4. Brain fiber bundle and brain Diffusion index

    Based on diffusion tensor imaging, the changes of brain fiber bundle and brain diffusion index before and after the Head-Down tilt Bed Rest test were compared.

    Measured: 60 days after the Head-Down tilt Bed Rest test

  5. Brain blood flow

    Based on arterial spin labeling, the changes of brain blood flow before and after the Head-Down tilt Bed Rest test were compared.

    Measured: 60 days after the Head-Down tilt Bed Rest test

  6. Imaging indexes and clinical scale scores

    Based on the changes of relevant imaging indexes and the changes of relevant clinical scale scores, explore the correlation between the changes of relevant imaging indexes and relevant clinical scales scores.

    Measured: 60 days after the Head-Down tilt Bed Rest test

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Apr 2024
  2. Study start1 Jan 2022
  3. Primary completion31 Oct 2024 (estimated)
  4. Study completion31 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
26 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06350422
Sponsor's protocol ID
Microgravity-ChinaPLAGH
Status last verified
Apr 2024
First submitted
1 Apr 2024
Last updated
5 Apr 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Microgravity and Neuroplasticity, run by Chinese PLA General Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Local brain functional activity (time frame: 60 days after the Head-Down tilt Bed Rest test). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in